China Resources Double-Crane Pharmaceutical Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 1.18%

China Resources Double-Crane Pharmaceutical Co Ltd (600062) has an Asset Resilience Ratio of 1.18% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 600062 current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

CN¥200.64 Million

≈ $29.36 Million USD Cash + Short-term Investments

Total Assets

CN¥17.01 Billion

≈ $2.49 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2000–2023)

This chart shows how China Resources Double-Crane Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see how large is China Resources Double-Crane Pharmaceuti's balance sheet.

Liquid Assets Composition Over Time

This chart breaks down China Resources Double-Crane Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore long-term investment intensity of China Resources Double-Crane Pharmaceuti to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥200.64 Million	1.18%
Total Liquid Assets	CN¥200.64 Million	1.18%

Asset Resilience Insights

Limited Liquidity: China Resources Double-Crane Pharmaceutical Co Ltd maintains only 1.18% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

China Resources Double-Crane Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare China Resources Double-Crane Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Drug Manufacturers - Specialty & Generic	1.54%
Viatris Inc NASDAQ:VTRS	Drug Manufacturers - Specialty & Generic	1.48%
Dr. Reddy's Laboratories Limited F:RDDA	Drug Manufacturers - Specialty & Generic	11.36%
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Drug Manufacturers - Specialty & Generic	0.20%
Hubei Jumpcan Pharmaceutical Co Ltd SHG:600566	Drug Manufacturers - Specialty & Generic	48.48%
Apeloa Pharmaceutical Co Ltd SHE:000739	Drug Manufacturers - Specialty & Generic	0.00%
Zhejiang Huahai Pharmaceutical Co Ltd SHG:600521	Drug Manufacturers - Specialty & Generic	0.35%
Yipinhong Pharmaceutical Co Ltd Class A SHE:300723	Drug Manufacturers - Specialty & Generic	0.66%

Annual Asset Resilience Ratio for China Resources Double-Crane Pharmaceutical Co Ltd (2000–2023)

The table below shows the annual Asset Resilience Ratio data for China Resources Double-Crane Pharmaceutical Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2023-12-31	-0.03%	CN¥-4.88 Million ≈ $-714.09K	CN¥15.43 Billion ≈ $2.26 Billion	-1.42pp
2022-12-31	1.38%	CN¥200.49 Million ≈ $29.34 Million	CN¥14.48 Billion ≈ $2.12 Billion	-4.49pp
2021-12-31	5.88%	CN¥803.58 Million ≈ $117.59 Million	CN¥13.68 Billion ≈ $2.00 Billion	-0.99pp
2020-12-31	6.86%	CN¥851.95 Million ≈ $124.67 Million	CN¥12.42 Billion ≈ $1.82 Billion	+0.14pp
2019-12-31	6.72%	CN¥758.14 Million ≈ $110.94 Million	CN¥11.28 Billion ≈ $1.65 Billion	-1.80pp
2018-12-31	8.53%	CN¥878.68 Million ≈ $128.58 Million	CN¥10.31 Billion ≈ $1.51 Billion	+1.69pp
2017-12-31	6.83%	CN¥644.75 Million ≈ $94.35 Million	CN¥9.44 Billion ≈ $1.38 Billion	+5.01pp
2016-12-31	1.82%	CN¥150.22 Million ≈ $21.98 Million	CN¥8.24 Billion ≈ $1.21 Billion	-3.44pp
2015-12-31	5.26%	CN¥408.65 Million ≈ $59.80 Million	CN¥7.76 Billion ≈ $1.14 Billion	-2.29pp
2014-12-31	7.55%	CN¥500.00 Million ≈ $73.17 Million	CN¥6.62 Billion ≈ $968.61 Million	+7.55pp
2005-12-31	0.00%	CN¥120.00K ≈ $17.56K	CN¥3.81 Billion ≈ $558.00 Million	+0.00pp
2001-12-31	0.00%	CN¥2.60K ≈ $380.46	CN¥2.75 Billion ≈ $401.87 Million	-6.63pp
2000-12-31	6.63%	CN¥98.38 Million ≈ $14.40 Million	CN¥1.48 Billion ≈ $217.18 Million	--

pp = percentage points

About China Resources Double-Crane Pharmaceutical Co Ltd

SHG:600062 China Drug Manufacturers - Specialty & Generic

Market Cap

$2.45 Billion

CN¥16.76 Billion CNY

Market Cap Rank

#5571 Global

#1019 in China

Share Price

CN¥16.13

Change (1 day)

+0.69%

52-Week Range

CN¥15.60 - CN¥19.70

All Time High

CN¥33.06